1. null
   Yutaka Nezu et al, 2017 CrossRef
2. Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest
   Yong Zhao et al, 2016, Sci Rep CrossRef
3. Registered report: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
   Jia Li et al, 2015 CrossRef
4. MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44
   Jianhui Zuo et al, 2017, Mol Cell Biochem CrossRef
5. Ternary Nanoparticles with a Sheddable Shell Efficiently Deliver MicroRNA-34a against CD44-Positive Melanoma.
   Minmin Fan et al, 2017, Mol Pharm CrossRef
6. MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines
   Cecilia M. Lopez et al, 2018, PLoS ONE CrossRef
7. A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy
   Yunfei He et al, 2017 CrossRef
8. MicroRNA-336 directly targets Sox-2 in osteosarcoma to inhibit tumorigenesis
   Yong Cao et al, 2017 CrossRef
9. MicroRNA-433 regulates apoptosis by targeting PDCD4 in human osteosarcoma cells
   Yinghua Sun et al, 2017 CrossRef
10. Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach
    Jyotika Varshney et al, 2016, Veterinary Sciences CrossRef
11. Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma
    Milad Asadi et al, 2018, J Gastrointest Canc CrossRef
12. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
    Yiqun Huang et al, 2018, Cancer Biomark CrossRef
13. Network regularised Cox regression and multiplex network models to predict disease comorbidities and survival of cancer
    Haoming Xu et al, 2015, Computational Biology and Chemistry CrossRef
14. miRNA signatures in childhood sarcomas and their clinical implications
    G. M. Viera et al, 2019, Clin Transl Oncol CrossRef
15. Noncoding RNAs as circulating biomarkers in osteosarcoma patients
    Gerardo Botti et al, 2019, J Cell Physiol CrossRef
16. Unraveling novel TF-miRNA regulatory crosstalk in metastasis of Soft Tissue Sarcoma
    Devyani Samantarrai et al, 2015, Sci Rep CrossRef
17. A causal role for circulating miR-34b in osteosarcoma.
    Q Tian et al, 2014, Eur J Surg Oncol CrossRef
18. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
    Yanfei Ma et al, 2013, Biochem Biophys Res Commun CrossRef
19. Dysregulation of MicroRNA-34a Expression in Colorectal Cancer Inhibits the Phosphorylation of FAK Via VEGF
    Danhua Zhang et al, 2014, Dig Dis Sci CrossRef
20. The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.
    Yang Shi et al, 2014, PLoS ONE CrossRef
21. MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours.
    Linli Tian et al, 2014, Tumour Biol. CrossRef
22. The p53/miR-34 axis in development and disease
    M. Rokavec et al, 2014, Journal of Molecular Cell Biology CrossRef
23. Degradable Hyaluronic Acid/Protamine Sulfate Interpolyelectrolyte Complexes as miRNA-Delivery Nanocapsules for Triple-Negative Breast Cancer Therapy
    Shihua Wang et al, 2015, Adv. Healthcare Mater. CrossRef
24. VEGF-mediated suppression of cell proliferation and invasion by miR-410 in osteosarcoma
    Dong Zhao et al, 2015, Mol Cell Biochem CrossRef
25. Prognostic implication of CD57, CD16, and TGF-β expression in oral squamous cell carcinoma.
    Nasim Taghavi et al, 2016, J Oral Pathol Med CrossRef
26. The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients
    Ji Hyung Hong et al, 2015, Tumor Biol. CrossRef
27. Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth
    Yong Zhao et al, 2015, Biochemical Pharmacology CrossRef
28. null
    Tomohiro Fujiwara et al, 2016 CrossRef
29. Effect and mechanism of miR-34a on proliferation, apoptosis and invasion of laryngeal carcinoma cells
    Ju-Xiang Wang et al, 2016, Asian Pacific Journal of Tropical Medicine CrossRef
30. Genetic factors conferring metastasis in osteosarcoma
    Vadim V Maximov et al, 2016, Future Oncology CrossRef
31. Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network
    De-min Jiao et al, 2017, PLoS ONE CrossRef
32. The potential combinational effect of miR-34a with celecoxib in osteosarcoma
    Xia Chen et al, 2017, Anti-Cancer Drugs CrossRef
33. MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2
    Xi Xie et al, 2017 CrossRef
34. The DNMT1/miR-34a Axis Is Involved in the Stemness of Human Osteosarcoma Cells and Derived Stem-Like Cells
    Xiao Liang et al, 2019, Stem Cells International CrossRef
35. LncRNA SNHG7/miR-34a-5p/SYVN1 axis plays a vital role in proliferation, apoptosis and autophagy in osteoarthritis.
    Feng Tian et al, 2020, Biol Res CrossRef
36. ABC Efflux Transporters and the Circuitry of miRNAs: Kinetics of Expression in Cancer Drug Resistance
    Bruno C. Gomes et al, 2020, IJMS CrossRef
37. Co-treatment of tumor cells with hyaluronan plus doxorubicin affects endothelial cell behavior independently of VEGF expression
    Daiana L. Vitale et al, 2018, Oncotarget CrossRef
38. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma
    Tomohiro Fujiwara et al, 2017, Oncotarget CrossRef
39. MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene
    Youguang Pu et al, 2016, Oncotarget CrossRef
40. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
    Dimiter Avtanski, 0 CrossRef
41. Downregulation of miR‑136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma
    Yanchen Chu et al, 2019, Oncol Lett CrossRef
42. “Star” miR-34a and CXCR4 antagonist based nanoplex for binary cooperative migration treatment against metastatic breast cancer
    Xue Yang et al, 2020, Journal of Controlled Release CrossRef
43. null
    Olivia Alge et al, 2018 CrossRef
44. Role of microRNAs in the crosstalk between osteosarcoma cells and the tumour microenvironment
    Yong Lei et al, 2020, Journal of Bone Oncology CrossRef
45. The Mediation of miR-34a/miR-449c for Immune Cytokines in Acute Cold/Heat-Stressed Broiler Chicken
    Tao Li et al, 2020, Animals CrossRef
46. CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations
    Mohammad Mahmoudi Gomari et al, 2021, Mutation Research/Reviews in Mutation Research CrossRef
47. Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma
    Xiaobin Cui et al, 2014, J Exp Clin Cancer Res CrossRef
48. Prognostic role of CD44 expression in osteosarcoma: evidence from six studies
    Yu Liu et al, 2014, Diagn Pathol CrossRef
49. Autophagy Regulation by Crosstalk between miRNAs and Ubiquitination System
    Junyan Qu et al, 2021, IJMS CrossRef
50. microRNA-34 Family: From Mechanism to Potential Applications
    Chen Wang et al, 2022, The International Journal of Biochemistry & Cell Biology CrossRef
51. Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks
    Zhimin Yang et al, 2022, Cell Cycle CrossRef
52. CD44 In Sarcomas: A Comprehensive Review and Future Perspectives
    Enrique Fernández-Tabanera et al, 2022, Front. Oncol. CrossRef
53. MicroRNA34a is associated with chemotherapy resistance, metastasis, recurrence, survival, and prognosis in patient with osteosarcoma
    Hongyu Lian et al, 2022 CrossRef
54. MicroRNA expression in relation with clinical evolution of osteosarcoma
    Lucero Monterde-Cruz et al, 2020, Pathology - Research and Practice CrossRef
55. miRNAs as potential game-changers in bone diseases: Future medicinal and clinical Uses
    Ahmed S. Doghish et al, 2023, Pathology - Research and Practice CrossRef
56. The promising roles of exosomal microRNAs in osteosarcoma: A new insight into the clinical therapy
    Wen Tian et al, 2023, Biomedicine & Pharmacotherapy CrossRef
57. Targeted therapy using nanocomposite delivery systems in cancer treatment: highlighting miR34a regulation for clinical applications
    Muhammad Javed Iqbal et al, 2023, Cancer Cell Int CrossRef
58. The effect of temperature-control microwave on HELA and MG-63 cells.
    Zhenwei Ji et al, 2018, J Cancer Res Ther CrossRef
59. CD44 Modulates Cell Migration and Invasion in Ewing Sarcoma Cells
    Enrique Fernández-Tabanera et al, 2023, IJMS CrossRef
60. Polymer‐Initiating Caveolae‐Mediated Endocytosis and GSH‐Responsive MiR‐34a Gene Delivery System for Enhanced Orthotopic Triple Negative Breast Cancer Therapy
    Tian‐Yan Han et al, 2023, Adv Healthcare Materials CrossRef